09:47 AM EST - Cannara Biotech Inc. : Today announced its financial and operating results for the fiscal quarter ended February 28, 2026. The company generated $27.2 million in total net Q2 revenues, $11.6 million in gross profit before fair value adjustments or 43% of revenues, $6.0 million in adjusted EBITDA, and $2.9 million in operating cash flow. Cannara Biotech Inc.
shares T.LOVE are trading down $0.24 at $1.81.
